» Articles » PMID: 17705523

Evaluation of Tubulointerstitial Lesions' Severity in Patients with Glomerulonephritides: an NMR-based Metabonomic Study

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2007 Aug 21
PMID 17705523
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

An 1H NMR-based metabonomic approach was used to investigate the correlation of histopathologically assessed tubulointerstitial lesions with the urinary metabolite profile in 77 patients with glomerulonephritides submitted to renal biopsy. The presence of renal damage was predicted with a sensitivity of 96% and a specificity of 99%. Patients with mild, moderate, and severe tubulointerstitial lesions were progressively differentiated from the healthy individuals in the Orthogonal Signal Correction Partial Least-Squares-Discriminant Analysis (OSC/PLS-DA) models with a statistically significant separation between those with mild and with severe lesions. The onset of the tubulointerstitial lesions is characterized by decreased excretion of citrate, hippurate, glycine, and creatinine, whereas further deterioration is followed by glycosuria, selective aminoaciduria, total depletion of citrate and hippurate, and gradual increase in the excretion of lactate, acetate, and trimethylamine-N-oxide. NMR-based metabonomic urinalysis could contribute to the early evaluation of the severity of the renal damage and possibly to the monitoring of kidney function.

Citing Articles

Metabolite pathway alterations identified by magnetic resonance metabolomics in a proximal tubular epithelial cell line treated with TGF-β1.

Humphries T, Lee S, Urquhart A, Vesey D, Micallef A, Winterford C Physiol Rep. 2025; 13(4):e70249.

PMID: 39957082 PMC: 11830627. DOI: 10.14814/phy2.70249.


Untargeted Metabolomics by Ultra-High-Performance Liquid Chromatography Coupled with Electrospray Ionization-Quadrupole-Time of Flight-Mass Spectrometry Analysis Identifies a Specific Metabolomic Profile in Patients with Early Chronic Kidney Disease.

Glavan M, Socaciu C, Socaciu A, Gadalean F, Cretu O, Vlad A Biomedicines. 2023; 11(4).

PMID: 37189675 PMC: 10136192. DOI: 10.3390/biomedicines11041057.


Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male rats.

Martin W, Nair M, Chuah Y, Malmodin D, Pedersen A, Abrahamsson S Clin Sci (Lond). 2022; 136(21):1485-1511.

PMID: 36259366 PMC: 7613831. DOI: 10.1042/CS20220205.


Healthy and Chronic Kidney Disease (CKD) Dogs Have Differences in Serum Metabolomics and Renal Diet May Have Slowed Disease Progression.

Brunetto M, Ruberti B, Halfen D, Caragelasco D, Vendramini T, Pedrinelli V Metabolites. 2021; 11(11).

PMID: 34822440 PMC: 8623449. DOI: 10.3390/metabo11110782.


Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics.

Gooding J, Agrawal S, McRitchie S, Acuff Z, Merchant M, Klein J Kidney Int Rep. 2020; 5(1):81-93.

PMID: 31922063 PMC: 6943762. DOI: 10.1016/j.ekir.2019.09.010.